Impact of the Concomitant Use of Immunomodulator and a Lower Week 8 Partial Mayo Score on the Persistence of Adalimumab in Refractory Ulcerative Colitis.
Kumei S, Sakurai T, So S, Itaba S, Akiho H, Nakamura S, Kim H, Yamasaki M, Takatsu N, Maekawa R, Sakemi R, Watanabe T, Shibata M, Kume K, Yoshikawa I, Takaki Y, Harada M.
Kumei S, et al. Among authors: yoshikawa i.
Intern Med. 2021 Dec 15;60(24):3849-3856. doi: 10.2169/internalmedicine.7279-21. Epub 2021 Jun 12.
Intern Med. 2021.
PMID: 34121007
Free PMC article.